img

Docetaxel Market Status and Trend Analysis 2017-2034 (COVID-19 Version)


Published on: 2024-01-04 | No of Pages : 116 | Industry : Life & Medical

Publisher : 9 | Format : PDF

Docetaxel Market Status and Trend Analysis 2017-2034 (COVID-19 Version)

Summary

Further key aspects of the report indicate that
Chapter 1Research ScopeProduct Definition, Type, End-Use & Methodology
Chapter 2Global Industry Summary
Chapter 3Market Dynamics
Chapter 4Global Market Segmentation by region, type and End-Use
Chapter 5North America Market Segmentation by region, type and End-Use
Chapter 6Europe Market Segmentation by region, type and End-Use
Chapter 7Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8South America Market Segmentation by region, type and End-Use
Chapter 9Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10Market Competition by Companies
Chapter 11Market forecast and environment forecast.
Chapter 12Industry Summary.

The global Docetaxel market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.


Based on the type of product

the global Docetaxel market segmented into
40 mg/ml
20 mg/ml
10 mg/ml

Based on the end-use

the global Docetaxel market classified into
Breast cancer
Non-small cell lung cancer
Prostate cancer
Gastric adenocarcinoma cancer
Head and neck cancer

Based on geography

the global Docetaxel market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are


Sanofi-Aventis
Pfizer
Teva
Taj Pharmaceuticals
Dr. Reddy
Sandoz
Actavis
Sun pharma
Beijing Union Pharmaceutical
Cisen Pharmaceutical
Qilu Pharma
Taiji Group
Jiangsu Hengrui
Accord Healthcare
Eagle Pharmaceuticals

Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL DOCETAXEL INDUSTRY
2.1 Summary about Docetaxel Industry
2.2 Docetaxel Market Trends
2.2.1 Docetaxel Production & Consumption Trends
2.2.2 Docetaxel Demand Structure Trends
2.3 Docetaxel Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 40 mg/ml
4.2.2 20 mg/ml
4.2.3 10 mg/ml
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Breast cancer
4.3.2 Non-small cell lung cancer
4.3.3 Prostate cancer
4.3.4 Gastric adenocarcinoma cancer
4.3.5 Head and neck cancer
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 40 mg/ml
5.2.2 20 mg/ml
5.2.3 10 mg/ml
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Breast cancer
5.3.2 Non-small cell lung cancer
5.3.3 Prostate cancer
5.3.4 Gastric adenocarcinoma cancer
5.3.5 Head and neck cancer
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 40 mg/ml
6.2.2 20 mg/ml
6.2.3 10 mg/ml
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Breast cancer
6.3.2 Non-small cell lung cancer
6.3.3 Prostate cancer
6.3.4 Gastric adenocarcinoma cancer
6.3.5 Head and neck cancer
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 40 mg/ml
7.2.2 20 mg/ml
7.2.3 10 mg/ml
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Breast cancer
7.3.2 Non-small cell lung cancer
7.3.3 Prostate cancer
7.3.4 Gastric adenocarcinoma cancer
7.3.5 Head and neck cancer
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 40 mg/ml
8.2.2 20 mg/ml
8.2.3 10 mg/ml
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Breast cancer
8.3.2 Non-small cell lung cancer
8.3.3 Prostate cancer
8.3.4 Gastric adenocarcinoma cancer
8.3.5 Head and neck cancer
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 40 mg/ml
9.2.2 20 mg/ml
9.2.3 10 mg/ml
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Breast cancer
9.3.2 Non-small cell lung cancer
9.3.3 Prostate cancer
9.3.4 Gastric adenocarcinoma cancer
9.3.5 Head and neck cancer
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Sanofi-Aventis
10.1.2 Pfizer
10.1.3 Teva
10.1.4 Taj Pharmaceuticals
10.1.5 Dr. Reddy
10.1.6 Sandoz
10.1.7 Actavis
10.1.8 Sun pharma
10.1.9 Beijing Union Pharmaceutical
10.1.10 Cisen Pharmaceutical
10.1.11 Qilu Pharma
10.1.12 Taiji Group
10.1.13 Jiangsu Hengrui
10.1.14 Accord Healthcare
10.1.15 Eagle Pharmaceuticals
10.2 Docetaxel Sales Date of Major Players (2017-2020e)
10.2.1 Sanofi-Aventis
10.2.2 Pfizer
10.2.3 Teva
10.2.4 Taj Pharmaceuticals
10.2.5 Dr. Reddy
10.2.6 Sandoz
10.2.7 Actavis
10.2.8 Sun pharma
10.2.9 Beijing Union Pharmaceutical
10.2.10 Cisen Pharmaceutical
10.2.11 Qilu Pharma
10.2.12 Taiji Group
10.2.13 Jiangsu Hengrui
10.2.14 Accord Healthcare
10.2.15 Eagle Pharmaceuticals
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Docetaxel Product Type Overview
Table Docetaxel Product Type Market Share List
Table Docetaxel Product Type of Major Players
Table Brief Introduction of Sanofi-Aventis
Table Brief Introduction of Pfizer
Table Brief Introduction of Teva
Table Brief Introduction of Taj Pharmaceuticals
Table Brief Introduction of Dr. Reddy
Table Brief Introduction of Sandoz
Table Brief Introduction of Actavis
Table Brief Introduction of Sun pharma
Table Brief Introduction of Beijing Union Pharmaceutical
Table Brief Introduction of Cisen Pharmaceutical
Table Brief Introduction of Qilu Pharma
Table Brief Introduction of Taiji Group
Table Brief Introduction of Jiangsu Hengrui
Table Brief Introduction of Accord Healthcare
Table Brief Introduction of Eagle Pharmaceuticals
Table Products & Services of Sanofi-Aventis
Table Products & Services of Pfizer
Table Products & Services of Teva
Table Products & Services of Taj Pharmaceuticals
Table Products & Services of Dr. Reddy
Table Products & Services of Sandoz
Table Products & Services of Actavis
Table Products & Services of Sun pharma
Table Products & Services of Beijing Union Pharmaceutical
Table Products & Services of Cisen Pharmaceutical
Table Products & Services of Qilu Pharma
Table Products & Services of Taiji Group
Table Products & Services of Jiangsu Hengrui
Table Products & Services of Accord Healthcare
Table Products & Services of Eagle Pharmaceuticals
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Docetaxel Market Forecast (Million USD) by Region 2021f-2026f
Table Global Docetaxel Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Docetaxel Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Docetaxel Market Forecast (Million USD) Share by Demand 2021f-2026f